A prospective study to evaluate the safety and efficacy of intravenous ferumoxytol (Feraheme) in patients with ST-elevation myocardial infarction (STEMI).
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- Acronyms CMR
Most Recent Events
- 05 Dec 2015 New trial record